14 May '11, 9pm

Drug Name? FDA Seeks to Prevent Mix-Ups:

Drug Name? FDA Seeks to Prevent Mix-Ups:

Oxcarbazepine or Oxandrolone. Omacor or Amacar, Ritalin or Rifadin. When it comes to drug names, the potential for confusion is sky-high. As Gregory Warner reports on Marketplace , drug companies spend billions figuring out what to name drugs but mix-ups still happen, and the Food and Drug Administration is taking steps to avoid such confusion. It's not a moment too soon for the FDA to step in. Warner interviews "professional drug namer" George DiDomizio who came up with the likes of Pepcid, Bextra, Prilosec, and many others: Naming a drug, he says, is harder than naming a cereal or a car because there's a whole other agency involved: the Food and Drug Administration. The FDA even has a special unit just to decide if the name over-promises. So, no "Panaciums" or "Correct-Alls." DIDOMIZIO: Some years ago I was working with J&J on an hormonal supplement called "Perfest." P-E...

Full article: http://www.care2.com/causes/health-policy/blog/whats-in-a...

Tweets